LabID-base/OpenAlex-Afillation huggingface dataset:
HPR144 Narrative Review of Total Quality-Adjusted Life Year (QALY) Gains From Oncology Medicines Reimbursed From 2020 To 2025 in Ireland
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: Caolan Halpin
raw_affiliation_strings: Pfizer, Dublin, Ireland
raw_author_name: Sophie Blaney
raw_affiliation_strings: Pfizer, Dublin, Ireland
raw_author_name: Ian Thompson
raw_affiliation_strings: Pfizer, Dublin, Ireland
HTA117 Dutch Cost Implications of Faricimab in Neovascular Age-Related Macular Degeneration: A Systematic Review of Treatment Interval and Injection Frequency
Year: 2025
Type: article
Language: en
Topic: Retinal Diseases and Treatments
Authors and affiliations:
raw_author_name: Mohamed El Alili
raw_affiliation_strings: Roche Nederland BV, Woerden, Netherlands
raw_author_name: Celine van de Laar
raw_affiliation_strings: Roche Nederland BV, Woerden, Netherlands
raw_author_name: Jeroen de Greeff
raw_affiliation_strings: Roche Nederland BV, Woerden, Netherlands
raw_author_name: Han Vromans
raw_affiliation_strings: Roche Nederland BV, Woerden, Netherlands
HTA361 What Did Time Reveal Evaluating the Accuracy of Parametric Model Predictions Against Long-Term Observed Data for Larotrectinib?
Year: 2025
Type: article
Language: en
Topic: Melanoma and MAPK Pathways
Authors and affiliations:
raw_author_name: Noman Paracha
raw_affiliation_strings: Bayer Consumer Care AG, Basel, Switzerland
raw_author_name: Jamie Grossman
raw_affiliation_strings: Bayer Healthcare LLC, Westerville, OH, USA
raw_author_name: Sarah Ba
raw_affiliation_strings: Bayer Public Limited Company, Reading, United Kingdom
raw_author_name: Federico Manevy
raw_affiliation_strings: Bayer Consumer Care AG, Basel, Switzerland
HSD108 The Micro-Meso-Macro (3M) Impact Framework: Capturing Health System Value Across Interacting Levels
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: Sonja Haut
raw_affiliation_strings: Novartis International AG, Basel, Switzerland
raw_author_name: Alvar Bucher
raw_affiliation_strings: Novartis International AG, Basel, Switzerland
raw_author_name: Ahmed Hesham Seddik
raw_affiliation_strings: University Medical Center, Groningen, Netherlands
raw_author_name: Dennis Alexander Ostwald
raw_affiliation_strings: WifOR Institute, Darmstadt, Germany
raw_author_name: Mark Lightowler
raw_affiliation_strings: Ernst & Young AG, Basel, Switzerland
raw_author_name: Rebecca Grün
raw_affiliation_strings: WifOR Institute, Darmstadt, Germany
raw_author_name: Malina Müller
raw_affiliation_strings: Head of Health Economics, WifOR Institute, Darmstadt, Germany
EPH35 Cardiovascular Event Rate and Mortality Among Primary-Prevention Hypercholesterolemia Patients in Japan
Year: 2025
Type: article
Language: en
Topic: Lipoproteins and Cardiovascular Health
Authors and affiliations:
raw_author_name: Tomohiro Kondo
raw_affiliation_strings: HEOR/RWE, Otsuka Phamaceutical Co., Ltd., Minato-ku, Japan
raw_author_name: Yilong Zhang
raw_affiliation_strings: Otsuka phama, Tokyo, Japan
raw_author_name: Kentaro Yamato
raw_affiliation_strings: Otsuka Holdings Co., Ltd., Tokyo, Japan
PT5 Pulmonary Nodule (PN)-Related and Lung Cancer-Related Workup Costs Within the Two-Year Period After Diagnosis of a PN in the United States
Year: 2025
Type: article
Language: en
Topic: Lung Cancer Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Kimberly Le
raw_affiliation_strings: Director of HEOR, Biodesix, spring hill, FL, USA
raw_author_name: Jonathan Scott Kurman
raw_affiliation_strings: Froedtert Hospital, Milwaukee, WI, USA
raw_author_name: Michelle Jerry
raw_affiliation_strings: Merative, Ann Arbor, MI, USA
raw_author_name: Megan Richards
raw_affiliation_strings: Merative, Ann Arbor, MI, USA
MT27 Impact of Companion Diagnostics (CDx) on Reimbursement Outcomes of Breast Cancer and NSCLC Therapies
Year: 2025
Type: article
Language: en
Topic: Breast Cancer Treatment Studies
Authors and affiliations:
raw_author_name: Konstantina Malliou Najjar
raw_affiliation_strings: Lane Clark and Peacock, London, United Kingdom
raw_author_name: Emily Ng
raw_affiliation_strings: Lane Clark and Peacock, London, United Kingdom
raw_author_name: Jasim Uddin
raw_affiliation_strings: Lane Clark and Peacock, London, United Kingdom
HTA276 Quality of Life and Productivity Costs in Cancer Patients Receiving Proton Therapy: A Predictive and Descriptive Study
Year: 2025
Type: article
Language: en
Topic: Radiation Therapy and Dosimetry
Authors and affiliations:
raw_author_name: Diego A. Larrotta-Castillo
raw_affiliation_strings: Erasmus School of Health Policy and Law, Rotterdam, Netherlands
raw_author_name: Margriet Sattler
raw_affiliation_strings: HollandPTC, Delft, Netherlands
raw_author_name: Michiel Kroesen
raw_affiliation_strings: HollandPTC, Delft, Netherlands
raw_author_name: Wouter Iserief
raw_affiliation_strings: Erasmus School of Health Policy and Law, Rotterdam, Netherlands
raw_author_name: Carin Uyl-De Groot
raw_affiliation_strings: Erasmus School of Health Policy and Law, Rotterdam, Netherlands
raw_author_name: Mischa Hoogeman
raw_affiliation_strings: HollandPTC, Delft, Netherlands
raw_author_name: Hedwig M. Blommestein
raw_affiliation_strings: Erasmus School of Health Policy and Law, Rotterdam, Netherlands
HTA326 The Phantom Menace: How Consultations and Appeals During NICE HST Appraisals Contribute to Delays in Patient Access
Year: 2025
Type: article
Language: en
Topic: Patient-Provider Communication in Healthcare
Authors and affiliations:
raw_author_name: Daniel Anzola
raw_affiliation_strings: STRATENYM Inc., Toronto, ON, Canada
raw_author_name: Daniela Gonçalves-Bradley
raw_affiliation_strings: STRATENYM Inc., Toronto, ON, Canada
raw_author_name: Christine Worsley
raw_affiliation_strings: STRATENYM Inc., Toronto, ON, Canada
HSD3 Access to Decide on a Generalization: Results From the EVA-Corse Experiment: Efficiency and Clinical Non-Inferiority of a Hybrid Cardiac Rehabilitation Model in Corsica
Year: 2025
Type: article
Language: en
Topic: Cardiac Health and Mental Health
Authors and affiliations:
raw_author_name: Camille Nevoret
raw_affiliation_strings: CEMKA, Bourg-la-Reine, France
raw_author_name: Antoine Faure
raw_affiliation_strings: CH de Bastia, Bastia, France
raw_author_name: Igor Giusti
raw_affiliation_strings: Fédération Corse pour la Coordination et l'Innovation en Santé (FCCIS), Bastia, France
raw_author_name: Stephane Bouee
raw_affiliation_strings: CEMKA, Bourg-la-Reine, France
raw_author_name: Frédéric Bousquet
raw_affiliation_strings: CNAM, Paris, France
raw_author_name: Annie Fouard
raw_affiliation_strings: Equipe Nationale, Ministère de la Santé, Paris, France
raw_author_name: Laura Bezannier
raw_affiliation_strings: CEMKA, Bourg-la-Reine, France
raw_author_name: Corinne Emery
raw_affiliation_strings: CEMKA, Bourg-la-Reine, France
raw_author_name: Valérie Donio
raw_affiliation_strings: CEMKA, Bourg-la-Reine, France
HTA105 Determinants of Willingness to Pay Thresholds in NICE Oncology Technology Appraisals
Year: 2025
Type: article
Language: en
Topic: Economic and Financial Impacts of Cancer
Authors and affiliations:
raw_author_name: Helen Bewicke-Copley
raw_affiliation_strings: Costello Medical, Edinburgh, United Kingdom
raw_author_name: Fern Woodhouse
raw_affiliation_strings: Costello Medical, Cambridge, United Kingdom
raw_author_name: Emma New
raw_affiliation_strings: Costello Medical, Singapore, Singapore
raw_author_name: Amrit Heir
raw_affiliation_strings: Costello Medical, Manchester, United Kingdom
raw_author_name: Briana Tan
raw_affiliation_strings: Costello Medical, Singapore, Singapore
raw_author_name: Jamie Graham
raw_affiliation_strings: Costello Medical, London, United Kingdom
raw_author_name: Josh Micallef
raw_affiliation_strings: Costello Medical, Cambridge, United Kingdom
raw_author_name: Alex Porteous
raw_affiliation_strings: Costello Medical, London, United Kingdom
HTA277 Readying for the Second Wave: What, When, and How Must Orphan Medicine Manufacturers Prepare for EU HTAR?
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: Daniel Newsome
raw_affiliation_strings: IQVIA, London, United Kingdom
raw_author_name: Edel Falla
raw_affiliation_strings: IQVIA, London, United Kingdom
raw_author_name: Sian Tanner
raw_affiliation_strings: IQVIA, Amsterdam, Netherlands
HSD97 Real-World Treatment Patterns Among Patients With Relapsed or Refractory (R/R) NPM1 Mutated (NPM1m) Acute Myeloid Leukemia (AML) in the United States (US)
Year: 2025
Type: article
Language: en
Topic: Acute Myeloid Leukemia Research
Authors and affiliations:
raw_author_name: Grace Gahlon
raw_affiliation_strings: Precision AQ, Bethesda, MD, USA
raw_author_name: Shailja Vaghela
raw_affiliation_strings: HealthEcon Consulting Inc., Ancaster, ON, Canada
raw_author_name: Lorena Lopez-Gonzalez
raw_affiliation_strings: Syndax Pharmaceuticals, Inc., New York, NY, USA
raw_author_name: Craig Freyer
raw_affiliation_strings: Syndax Pharmaceuticals, Inc., New York, NY, USA
raw_author_name: Shelby Corman
raw_affiliation_strings: Precision AQ, Bethesda, MD, USA
raw_author_name: Huan Huang
raw_affiliation_strings: Syndax Pharmaceuticals, Inc., New York, NY, USA
HTA337 Too Advanced for STA, Too Common for HST? Navigating NICE Appraisals of Gene Therapies
Year: 2025
Type: article
Language: en
Topic: Virus-based gene therapy research
Authors and affiliations:
raw_author_name: Evangelos Papastergios
raw_affiliation_strings: Symmetron, London, United Kingdom
raw_author_name: Bryony Langford
raw_affiliation_strings: Symmetron, London, United Kingdom
raw_author_name: Laura Sawyer
raw_affiliation_strings: Symmetron, London, United Kingdom
CO129 Healthcare Resource Utilization and Disease Progression in Patients With Primary Hyperoxaluria: A Retrospective Cohort Study
Year: 2025
Type: article
Language: en
Topic: Kidney Stones and Urolithiasis Treatments
Authors and affiliations:
raw_author_name: Anne Helene Olsen
raw_affiliation_strings: Novo Nordisk A/S, Bagsvaerd, Denmark
raw_author_name: Katarzyna Mosiewicz
raw_affiliation_strings: Novo Nordisk A/S, Bagsværd, Denmark
raw_author_name: Jack Garcia Uranga
raw_affiliation_strings: Novo Nordisk A/S, Bagsværd, Denmark
raw_author_name: Kirstine Belling
raw_affiliation_strings: Novo Nordisk A/S, Bagsværd, Denmark
CO81 Economic and Clinical Burden of Diagnosed Congenital Cytomegalovirus Disease in France During the First 2 Years of Life
Year: 2025
Type: article
Language: en
Topic: Cytomegalovirus and herpesvirus research
Authors and affiliations:
raw_author_name: Philip Buck
raw_affiliation_strings: Moderna, Inc., Cambridge, MA, USA
raw_author_name: Maryaline Catillon
raw_affiliation_strings: Analysis Group, Inc., New York, NY, USA
raw_author_name: Kathleen Chen
raw_affiliation_strings: Analysis Group, Inc., Montréal, QC, Canada
raw_author_name: Kirsten Gallant
raw_affiliation_strings: Analysis Group, Ltd., London, United Kingdom
raw_author_name: Victor Lhoste
raw_affiliation_strings: Analysis Group, Ltd., Paris, France
raw_author_name: Noam Kirson
raw_affiliation_strings: Analysis Group, Inc., Boston, MA, USA
raw_author_name: Urvi Desai
raw_affiliation_strings: Analysis Group, Inc., Boston, MA, USA
raw_author_name: John Diaz-Decaro
raw_affiliation_strings: Moderna, Inc., Cambridge, MA, USA
HTA69 Challenges at the Interface Between EUHTA (JCA) and National HTA in Germany (AMNOG): Expected Limitations to Synergy Effects and Implications for AMNOG Dossier Preparation
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: Marie Becker
raw_affiliation_strings: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
raw_author_name: Janika Drews
raw_affiliation_strings: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
raw_author_name: Sandra Gellert
raw_affiliation_strings: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
raw_author_name: Magdalena Oberhauser
raw_affiliation_strings: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
raw_author_name: Angelika Poppele
raw_affiliation_strings: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
raw_author_name: Caroline Scheulen
raw_affiliation_strings: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
raw_author_name: Penelope Gallinger
raw_affiliation_strings: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
raw_author_name: Doreen Bonduelle
raw_affiliation_strings: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
PCR121 Health-Related Quality of Life of Patients With Epidermolysis Bullosa in Hungary: Results With the EQ-5D-5L and EQ-5D-Y-3L Preference-Based Measurement Tools
Year: 2025
Type: article
Language: en
Topic: Skin and Cellular Biology Research
Authors and affiliations:
raw_author_name: Marta Pentek
raw_affiliation_strings: Health Economics Research Center, University Research and Innovation Center, Obuda University, Budapest, Hungary
raw_author_name: Márta Medvecz
raw_affiliation_strings: Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary
raw_author_name: László Gulácsi
raw_affiliation_strings: Health Economics Research Center, University Research and Innovation Center, Obuda University, Budapest, Hungary
raw_author_name: Zsombor Zrubka
raw_affiliation_strings: Health Economics Research Center, University Research and Innovation Center, Obuda University, Budapest, Hungary
raw_author_name: Renata Linertová
raw_affiliation_strings: Canary Islands Health Research Institute Foundation (FIISC), Las Palmas de Gran Canaria, Spain
raw_author_name: Áron Hölgyesi
raw_affiliation_strings: Health Economics Research Center, University Research and Innovation Center, Obuda University, Budapest, Hungary
HPR122 Including Decision Uncertainty About the Clinically Minimal Important Difference: Shifting From Risk Aversion to Risk Awareness in Drug Reimbursement Processes
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: JL (Hans) Severens
raw_affiliation_strings: Owner/advisor, Severens HTA Consultancy, Venray, Netherlands
raw_author_name: Maarten Jacobus Postma
raw_affiliation_strings: University of Groningen, Groningen, Netherlands
raw_author_name: Mark Sculpher
raw_affiliation_strings: University of York, York, United Kingdom
CO1 A Balancing Act: Low-Dose Atropine Significantly Slows Pediatric Myopia Progression Without a Clinically Meaningful Risk of Rebound (Accelerated Myopia Progression Following Treatment Cessation)
Year: 2025
Type: article
Language: en
Topic: Ophthalmology and Visual Impairment Studies
Authors and affiliations:
raw_author_name: Jelena Jovanovic
raw_affiliation_strings: IQVIA, London, United Kingdom
raw_author_name: Maria Zacharioudaki
raw_affiliation_strings: IQVIA, Munich, Germany
raw_author_name: Georgios Papadakis
raw_affiliation_strings: IQVIA, Athens, Greece
raw_author_name: Marilena Kalatzi
raw_affiliation_strings: IQVIA, Athens, Greece
raw_author_name: Nagarjuna Mulkalapalli
raw_affiliation_strings: IQVIA, Gurugram, India
raw_author_name: Frederic Ernst
raw_affiliation_strings: Santen Pharmaceuticals, Munich, Germany
raw_author_name: Thom de Milliano
raw_affiliation_strings: Santen, Geneva, Switzerland
EE567 Live Attenuated Influenza Vaccination (LAIV) for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis
Year: 2025
Type: article
Language: en
Topic: Influenza Virus Research Studies
Authors and affiliations:
raw_author_name: Fryderyk Wilczynski
raw_affiliation_strings: Health Economics and Outcomes Research Ltd., Cardiff, United Kingdom
raw_author_name: Holly Prudden
raw_affiliation_strings: Health Economics and Outcomes Research Ltd., Cardiff, United Kingdom
raw_author_name: Sara Hallberg
raw_affiliation_strings: Nordic Health Technology Assessment, AstraZeneca, Gothenburg, Sweden
raw_author_name: Åsa Tormod
raw_affiliation_strings: Market Access Manager, AstraZeneca, Stockholm, Sweden
raw_author_name: Mikko Tuovinen
raw_affiliation_strings: Nordic Health Technology Assessment, AstraZeneca, Helsinki, Finland
raw_author_name: Amy Zhou
raw_affiliation_strings: Global Pricing and Market Access, Vaccine and Immune Therapies, AstraZeneca, Cambridge, United Kingdom
raw_author_name: Klas Bergenheim
raw_affiliation_strings: Health Economics & Payer Evidence, Vaccine and Immune Therapies, AstraZeneca, Gothenburg, Sweden
HTA60 Budget Impact Minimization Approaches Used Across Europe, Brazil, and Japan in the Reimbursement of Obesity Medications
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: Grace Miller
raw_affiliation_strings: Remap Consulting UK Ltd, Macclesfield, United Kingdom
raw_author_name: Vishal Chanda
raw_affiliation_strings: Remap Consulting UK Ltd, Macclesfield, United Kingdom
raw_author_name: Graham Foxon
raw_affiliation_strings: Remap Consulting UK Ltd, Macclesfield, United Kingdom
CO12 APDS Treatment in Germany: Decision Criteria, Costs, and Contribution of Leniolisib to Outcomes
Year: 2025
Type: article
Language: en
Topic: Immunodeficiency and Autoimmune Disorders
Authors and affiliations:
raw_author_name: Ulrich Baumann
raw_affiliation_strings: Immunology Unit, Paediatric Pulmonology, Allergy and Neonatology, Hannover Medical School (MHH), Hannover, Germany
raw_author_name: Marie-Celine Deau
raw_affiliation_strings: Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
raw_author_name: Karsten Franke
raw_affiliation_strings: Institute of Clinical Immunology, Siegen, Germany
raw_author_name: Leif G. Hanitsch
raw_affiliation_strings: Charité – Universitätsmedizin Berlin, Berlin, Germany
raw_author_name: Georgios Sogkas
raw_affiliation_strings: Department of Rheumatology and Immunology, Hannover Medical School (MHH), Hannover, Germany
raw_author_name: Kirsten H. Herrmann
raw_affiliation_strings: Pharming, Leiden, Netherlands
raw_author_name: Ulrich Bosch dos Santos
raw_affiliation_strings: Pharming, Leiden, Netherlands
raw_author_name: Christof Minartz
raw_affiliation_strings: Institute for Health- and Pharmacoeconomics (IfGPh), Muenchen, Germany
raw_author_name: Aljoscha S. Neubauer
raw_affiliation_strings: Institute for Health- and Pharmacoeconomics (IfGPh), Muenchen, Germany
raw_author_name: Fabian Hauck
raw_affiliation_strings: Division of Pediatric Immunology and Rheumatology, Department of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Muenchen, Germany
PCR219 Socioeconomic Burden of Pulmonary Arterial Hypertension on Patients and Caregivers in the Czech Republic
Year: 2025
Type: article
Language: en
Topic: Pulmonary Hypertension Research and Treatments
Authors and affiliations:
raw_author_name: Pavel Jansa
raw_affiliation_strings: 2nd Department of Medicine—Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic
raw_author_name: Lucie Miksova
raw_affiliation_strings: 2nd Department of Medicine—Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic
raw_author_name: Marcel Ourada
raw_affiliation_strings: 2nd Department of Medicine—Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic
raw_author_name: Vladimir Dytrych
raw_affiliation_strings: 2nd Department of Medicine—Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic
raw_author_name: Jan Precek
raw_affiliation_strings: Department of Internal Medicine I - Cardiology, Faculty of Medicine and Dentistry, Palacky University and Olomouc University Hospital, Olomouc, Czech Republic
raw_author_name: Jana Alahakoon
raw_affiliation_strings: MSD, Prague, Czech Republic
raw_author_name: Tomas Mlcoch
raw_affiliation_strings: MSD, Prague, Czech Republic
raw_author_name: Jakub Zadak
raw_affiliation_strings: MSD, Prague, Czech Republic
raw_author_name: Tomáš Doležal
raw_affiliation_strings: Value Outcomes, Prague, Czech Republic
raw_author_name: Katerina Doleckova
raw_affiliation_strings: Value Outcomes, Prague, Czech Republic
raw_author_name: Lada Souza
raw_affiliation_strings: Value Outcomes, Prague, Czech Republic
raw_author_name: Martin Hutyra
raw_affiliation_strings: Department of Internal Medicine I - Cardiology, Faculty of Medicine and Dentistry, Palacky University and Olomouc University Hospital, Olomouc, Czech Republic
PCR35 Can We Quantify the Financial Impact of Patient-Reported Outcomes on the Value of Oncology Products?
Year: 2025
Type: article
Language: en
Topic: Economic and Financial Impacts of Cancer
Authors and affiliations:
raw_author_name: Francesco Cottone
raw_affiliation_strings: Daiichi Sankyo, Rome, Italy
raw_author_name: Meredith Venerus
raw_affiliation_strings: Daiichi Sankyo España, Madrid, Spain
raw_author_name: Ashna Alladin
raw_affiliation_strings: IQVIA Patient Centered Solutions, Munich, Germany
raw_author_name: Robert Friedrich Krüger
raw_affiliation_strings: IQVIA, Bad Homburg, Germany
raw_author_name: Livia Lai
raw_affiliation_strings: IQVIA, Reading, United Kingdom
raw_author_name: Mats Rosenlund
raw_affiliation_strings: Daiichi-Sankyo, Danderyd, Sweden
EPH96 Evidence-Driven Simulated Agents to Train Reinforcement Learning for Personalization in mHealth Interventions
Year: 2025
Type: article
Language: en
Topic: Digital Mental Health Interventions
Authors and affiliations:
raw_author_name: Juan Carlos Caro
raw_affiliation_strings: Universidad de Concepcion, Concepcion, Chile
raw_author_name: Giorgio Galgano
raw_affiliation_strings: Universidad de Concepcion, Concepcion, Chile
EPH38 Care of Patients With Phenylketonuria (PKU) in Germany a Claims Data Analysis From 2013 to 2023
Year: 2025
Type: article
Language: en
Topic: Metabolism and Genetic Disorders
Authors and affiliations:
raw_author_name: Axel Boehnke
raw_affiliation_strings: Director Market Access EU North, PTC Therapeutics Germany GmbH, Frankfurt, Germany
raw_author_name: Lisa-Marie Mueller
raw_affiliation_strings: Gesundheitsforen Leipzig, Leipzig, Germany
raw_author_name: Constantin Heidecke
raw_affiliation_strings: Gesundheitsforen Leipzig, Leipzig, Germany
raw_author_name: Alexa Benson
raw_affiliation_strings: Gesundheitsforen Leipzig, Leipzig, Germany
raw_author_name: Aljoscha S. Neubauer
raw_affiliation_strings: IfGPh Institut für Gesundheits- und Pharmakoökonomie GmbH, Muenchen, Germany
raw_author_name: Ania C. Muntau
raw_affiliation_strings: University Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Child and Adolescent Health (DZKJ), Hamburg, Germany
HTA291 Rising EAP Rejection Rates and Their Impact on Drug Access in France
Year: 2025
Type: article
Language: en
Topic: Biomedical Ethics and Regulation
Authors and affiliations:
raw_author_name: Fernando Rosas
raw_affiliation_strings: Trinity Life Sciences, Ciudad de Mexico, Mexico
raw_author_name: Maximilian Hunt
raw_affiliation_strings: Trinity Life Sciences, New York, NY, USA
raw_author_name: Ismail Ismailoglu
raw_affiliation_strings: Principal, Trinity Life Sciences, Minneapolis, MN, USA
raw_author_name: Andreia Ribeiro
raw_affiliation_strings: Trinity Life Sciences, Matosinhos, Portugal